Jul 10, 2026BoardMeeting
BoardControlled Substances Board Meeting
The Board meeting included discussions on administrative matters such as the appointment of liaisons, board member reports, and rule matters involving the scheduling of various substances like Bromazolam, 3-methoxyphencyclidine, and synthetic benzimidazole-opioids. Additionally, the agenda covered updates on the Prescription Drug Monitoring Program, deliberation on special use authorizations, and a review of referral criteria from the work group.